(19)
(11) EP 1 200 076 A1

(12)

(43) Date of publication:
02.05.2002 Bulletin 2002/18

(21) Application number: 00952319.2

(22) Date of filing: 31.07.2000
(51) International Patent Classification (IPC)7A61K 31/135
(86) International application number:
PCT/US0020/834
(87) International publication number:
WO 0108/673 (08.02.2001 Gazette 2001/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 31.07.1999 US 146778 P

(71) Applicants:
  • SmithKline Beecham Corporation
    Philadelphia, PA 19103 (US)
  • NPS PHARMACEUTICALS, INC.
    Salt Lake CityUtah 84108 (US)

(72) Inventors:
  • GOWEN, Maxine
    Bryn Mawr, PA 19010 (US)
  • SUVA, Larry, J.
    Wayne, PA 19087 (US)
  • FOX, John
    Salt Lake City, UT 84117 (US)
  • STROUP, George, B.
    Devon, PA 19333 (US)
  • NEMETH, Edward, F.
    Salt Lake City, UT 84124 (US)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) CALCILYTIC COMPOUNDS